Atsushi Hatanaka
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The transcription factor NRF1 (NFE2L1) activates aggrephagy by inducing p62 and GABARAPL1 after proteasome inhibition to maintain proteostasis.
Journal: Scientific reports
Published: June 10, 2023
NRF3 activates mTORC1 arginine-dependently for cancer cell viability.
Journal: iScience
Published: September 06, 2022
NFE2L1 and NFE2L3 Complementarily Maintain Basal Proteasome Activity in Cancer Cells through CPEB3-Mediated Translational Repression.
Journal: Molecular and cellular biology
Published: January 09, 2020
NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein.
Journal: Molecular and cellular biology
Published: November 20, 2019
β-Catenin/TCF4 Complex-Mediated Induction of the NRF3 (NFE2L3) Gene in Cancer Cells.
Journal: International journal of molecular sciences
Published: April 14, 2019
Identification of novel lysine demethylase 5-selective inhibitors by inhibitor-based fragment merging strategy.
Journal: Bioorganic & medicinal chemistry
Published: December 25, 2018
Possible roles of the transcription factor Nrf1 (NFE2L1) in neural homeostasis by regulating the gene expression of deubiquitinating enzymes.
Journal: Biochemical and biophysical research communications
Published: December 30, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026